Correlation Between Shin Kong and GeneFerm Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shin Kong and GeneFerm Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shin Kong and GeneFerm Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shin Kong Financial and GeneFerm Biotechnology Co, you can compare the effects of market volatilities on Shin Kong and GeneFerm Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shin Kong with a short position of GeneFerm Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shin Kong and GeneFerm Biotechnology.

Diversification Opportunities for Shin Kong and GeneFerm Biotechnology

-0.53
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Shin and GeneFerm is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Shin Kong Financial and GeneFerm Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneFerm Biotechnology and Shin Kong is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shin Kong Financial are associated (or correlated) with GeneFerm Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneFerm Biotechnology has no effect on the direction of Shin Kong i.e., Shin Kong and GeneFerm Biotechnology go up and down completely randomly.

Pair Corralation between Shin Kong and GeneFerm Biotechnology

Assuming the 90 days trading horizon Shin Kong Financial is expected to generate 0.85 times more return on investment than GeneFerm Biotechnology. However, Shin Kong Financial is 1.18 times less risky than GeneFerm Biotechnology. It trades about 0.1 of its potential returns per unit of risk. GeneFerm Biotechnology Co is currently generating about -0.03 per unit of risk. If you would invest  810.00  in Shin Kong Financial on September 1, 2024 and sell it today you would earn a total of  345.00  from holding Shin Kong Financial or generate 42.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Shin Kong Financial  vs.  GeneFerm Biotechnology Co

 Performance 
       Timeline  
Shin Kong Financial 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Shin Kong Financial has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
GeneFerm Biotechnology 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in GeneFerm Biotechnology Co are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, GeneFerm Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Shin Kong and GeneFerm Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shin Kong and GeneFerm Biotechnology

The main advantage of trading using opposite Shin Kong and GeneFerm Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shin Kong position performs unexpectedly, GeneFerm Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneFerm Biotechnology will offset losses from the drop in GeneFerm Biotechnology's long position.
The idea behind Shin Kong Financial and GeneFerm Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
FinTech Suite
Use AI to screen and filter profitable investment opportunities